Capabilities
Resources
About
- Leadership
- Locations
Careers
Contact

Capabilities
Resources
About
- Leadership
- Locations
Careers
Contact

Press Releases

4 min read

JSR Appoints Veteran Biotech and CDMO Leader Mark W. Womack to Lead KBI Biopharma and Selexis SA

May 2, 2022

3 min read

KBI Biopharma Holds Ribbon Cutting for New Commercial Manufacturing Facility

Apr 21, 2022

4 min read

Oragenics Engages KBI Biopharma to Support Development of the Intranasal COVID-19 Vaccine Candidate NT-CoV2-1

Mar 10, 2022

3 min read

KBI Biopharma Completes Eurofins DiscoverX Products Specialized Bioassay Certification Program

Oct 11, 2021

3 min read

Adalta Secures AD-214 Resupply Under KBI Biopharma MSA

Jul 2, 2021

3 min read

Selexis and KBI Biopharma Enter into Agreements with Immatics for Integrated Approach to Advance Immatics TCR Bispecific Program Towards IND

Jun 29, 2021

4 min read

KBI Biopharma Enters Commercial Manufacturing Agreement with AM-Pharma to Prepare for the Commercial Launch of Lead Program in Acute Kidney Disease

Jun 17, 2021

4 min read

Durham Tech and KBI BioPharma Partner to Boost Diversity and Create Life Sciences Job Opportunities for North Carolina Students and Veterans

May 4, 2021

2 min read

BioPharm International | Maximum Output Starts with Optimized Upstream Processing

Apr 8, 2021

3 min read

KBI Biopharma Expands US Operations With New $150 Million Commercial Manufacturing Facility Based In RTP, North Carolina

Dec 1, 2020

Stay in the loop

KBI Biopharma is extremely active in the biotech and pharmaceutical research and development community. We regularly attend, sponsor and present at conferences around the world as well as publish in journals.

Capabilities
Resources
About Us
Careers
Contact Us

Privacy Policy

© 2022 KBI Biopharma